Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1805 | Thyroid cancer | ICEECE2012

Differentiated thyroid cancer and hemodialysis: Long-term outcomes and safety after radioiodine use.

Navarro Gonzalez E. , Martinez Ortega A. , Guerrero Vazquez R. , Martinez Brocca M. , Cuenca Cuenca J.

Introduction: The use of radioiodine is a common treatment for differentiated thyroid cancer. However, special care should be exercised in treating patients who are on hemodialysis, due to the renal elimination of the radionuclide, which implies several technical difficulties and safety concerns. We have previously described the procedure and the short-term outcome and safety in three patients (Jimenez et al, Thyroid 2001; 11(11):1031–1034). Our results showed that the ra...

ea0073pep9.8 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

Romero LLuch Ana R. , Disotuar Suset Dueñas , Tous Romero Marai C. , Fernández Peña J. Ignacio , Cuenca Cuenca J. Ignacio , Elena Navarro

IntroductionBased on the evidence available back then, in 2015 we developed a provincial multicenter protocol for screening and follow up of no-index patients with SDHB and SDHC mutations.Objectives1. To evaluate the performance of the protocol designed for the follow-up of asymptomatic SDHB and C carriers. 2. To describe the penetrance of manifestations associated with hereditary PGL-FEO syndromes type 3 and...